Jacobs Levy Equity Management’s Usana Health Sciences USNA Stock Holding History

Jacobs Levy Equity Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37M	Sell	192,976 -59,119	-23%	-$1.17M	0.01%	491
2025 Q4	$4.95M	Sell	252,095 -12,878	-5%	-$267K	0.02%	413
2025 Q3	$7.3M	Sell	264,973 -85,632	-24%	-$2.63M	0.03%	351
2025 Q2	$10.7M	Buy	350,605 +162,094	+86%	+$4.6M	0.04%	293
2025 Q1	$5.08M	Buy	188,511 +59,535	+46%	+$1.88M	0.02%	454
2024 Q4	$4.63M	Buy	128,976 +18,490	+17%	+$691K	0.02%	449
2024 Q3	$4.19M	Sell	110,486 -27,260	-20%	-$1.12M	0.02%	470
2024 Q2	$6.23M	Buy	137,746 +26,254	+24%	+$1.21M	0.03%	411
2024 Q1	$5.41M	Buy	111,492 +2,820	+3%	+$138K	0.02%	415
2023 Q4	$5.82M	Buy	108,672 +18,013	+20%	+$911K	0.03%	400
2023 Q3	$5.31M	Buy	90,659 +2,168	+2%	+$136K	0.03%	368
2023 Q2	$5.58M	Buy	88,491 +12,701	+17%	+$809K	0.03%	370
2023 Q1	$4.77M	Sell	75,790 -48,017	-39%	-$2.87M	0.03%	409
2022 Q4	$6.59M	Buy	123,807 +4,091	+3%	+$222K	0.04%	351
2022 Q3	$6.71M	Sell	119,716 -9,025	-7%	-$597K	0.05%	333
2022 Q2	$9.32M	Buy	128,741 +21,264	+20%	+$1.58M	0.07%	291
2022 Q1	$8.54M	Buy	107,477 +2,180	+2%	+$197K	0.06%	325
2021 Q4	$10.7M	Buy	105,297 +61,154	+139%	+$6.1M	0.07%	291
2021 Q3	$4.07M	Buy	44,143 +3,273	+8%	+$315K	0.03%	477
2021 Q2	$4.19M	Sell	40,870 -2,039	-5%	-$205K	0.03%	471
2021 Q1	$4.19M	Sell	42,909 -24,725	-37%	-$2.25M	0.03%	450
2020 Q4	$5.21M	Sell	67,634 -23,442	-26%	-$1.81M	0.05%	388
2020 Q3	$6.71M	Buy	91,076 +1,027	+1%	+$82.4K	0.07%	285
2020 Q2	$6.61M	Sell	90,049 -34,652	-28%	-$2.72M	0.07%	285
2020 Q1	$7.2M	Buy	124,701 +44,692	+56%	+$3.11M	0.09%	234
2019 Q4	$6.29M	Buy	+80,009	New	+$5.89M	0.06%	331
2019 Q2	–	Sell	-71,054	Closed	-$5.96M	–	1031
2019 Q1	$5.96M	Buy	71,054 +25,610	+56%	+$2.67M	0.09%	300
2018 Q4	$5.35M	Sell	45,444 -710	-2%	-$82.1K	0.09%	241
2018 Q3	$5.56M	Buy	46,154 +10,059	+28%	+$1.25M	0.08%	294
2018 Q2	$4.16M	Buy	+36,095	New	+$3.95M	0.07%	345
2017 Q2	–	Sell	-5,740	Closed	-$331K	–	1021
2017 Q1	$331K	Buy	5,740 +100	+2%	+$5.97K	0.01%	712
2016 Q4	$345K	Buy	+5,640	New	+$367K	0.01%	742
2016 Q1	–	Sell	-4,700	Closed	-$300K	–	1185
2015 Q4	$300K	Hold	4,700	–	–	0.01%	648
2015 Q3	$315K	Buy	+4,700	New	+$332K	0.01%	643
2014 Q3	–	Sell	-6,280	Closed	-$245K	–	911
2014 Q2	$245K	Buy	6,280 +600	+11%	+$22.3K	﹤0.01%	739
2014 Q1	$214K	Buy	+5,680	New	+$198K	﹤0.01%	812

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management's USNA Position: Q1 2026 in Review

Jacobs Levy Equity Management reduced its Usana Health Sciences (USNA) stake by 23% in Q1 2026, selling an estimated $1.17M and leaving 192,976 shares worth $3.37M. The position accounts for 0.01% of the portfolio, ranked #491.

Jacobs Levy Equity Management first reported a position in USNA in Q1 2014 and has held it in 36 quarters since. The position peaked at $10.7M in Q2 2025. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

Jacobs Levy Equity Management held 192,976 shares of Usana Health Sciences worth $3.37M as of Q1 2026.
Jacobs Levy Equity Management sold 59,119 Usana Health Sciences shares in Q1 2026, an estimated $1.17M.
Usana Health Sciences made up 0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #491 holding.
Jacobs Levy Equity Management first reported a position in Usana Health Sciences in Q1 2014 and has held it in 36 quarters since.
Jacobs Levy Equity Management's Usana Health Sciences position peaked at $10.7M in Q2 2025.
139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.